Aethlon Medical Market Cap 2010-2024 | AEMD

Aethlon Medical market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Aethlon Medical market cap as of November 04, 2024 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.005B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $524.095B 21.00
Cigna Group (CI) United States $88.033B 11.51
Centene (CNC) United States $32.069B 9.41
Humana (HUM) United States $31.392B 14.29
Molina Healthcare (MOH) United States $18.690B 14.87
Select Medical Holdings (SEM) United States $4.654B 16.12
Joint (JYNT) United States $0.166B 554.00